+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2023-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989664
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 21.11 billion in 2022, USD 22.73 billion in 2023, and is expected to grow at a CAGR of 7.74% to reach USD 38.34 billion by 2030.

The clinical trial supply chain is a critical aspect of the pharmaceutical industry, as it involves the storage, distribution, and monitoring of investigational medicinal products (IMPs) used in clinical studies. Clinical trial logistics primarily aim to ensure that the essential resources are available at the right time, place, and under optimal conditions to maintain quality throughout the trial process. Clinical trial supply & logistics plays a vital role in the overall success of drug development programs by directly impacting cost management, risk mitigation, efficiency improvement, and patient safety. Some major trends contributing to this industry growth include the globalization of clinical trials, the adoption of technology-driven solutions, and the outsourcing of non-core functions within pharmaceutical companies. The growth of the clinical trial supply & logistics (CTSL) market has been significantly influenced by the increasing Research and Development (R&D) expenditure in the pharmaceutical sector. Pharmaceutical R&D is vital in developing innovative drugs and therapies that improve healthcare outcomes worldwide. The continuous expansion in R&D investments has propelled advancements in clinical trial processes, leading to robust growth in the clinical trial supply & logistics industry. The pharmaceutical industry has faced significant challenges due to the escalating drug development costs and clinical trials. These increased expenses have substantially impacted various aspects of the industry, leading to reduced investment by pharmaceutical companies in their clinical trial supply chain management systems. In recent years, the pharmaceutical industry substantially increased in outsourcing clinical trial activities to contract research organizations (CROs) and other third-party service providers. Multiple factors drive this trend, including the need for cost reduction, access to specialized expertise, and the demand for faster drug development processes, which has significantly supplemented growth in the clinical trial supply chain and logistics services.

Regional Insights

Americas has endured a significant position in the pharmaceutical market's clinical trial supply & logistics due to the adoption of technologically advanced products, well-established regulatory agencies, and considerable contract research organizations. The United States is increasingly focusing on generics and biologics, both cost-effective alternatives to traditional pharmaceuticals. The market has witnessed an increase in business growth with rising demand for generic prescription drugs that the FDA has approved to be the equivalent of a brand-name drug in dosage, safety, strength, quality, performance, and intended use. Asia-Pacific's expanding technology sector and enhancement in the pharmaceutical services in emerging countries such as China, Korea, and India create several growth opportunities for supply chain management solutions. In contrast, countries such as Australia, Japan, and Singapore represent the developed healthcare systems in the region. EMEA clinical trial supply & logistics for the pharmaceutical market has focused on the re-oriented healthcare and pharmaceutical systems to ensure efficient service delivery. The European region represents the developed market, closely following the developed market's technological and healthcare development trends. The European Union (EU) plays a significant role in the pharmaceutical industry and is a substantial trader in pharmaceuticals and medicinal products. Manufacturing and distribution have also become increasingly globalized, with the maintenance of supply & logistics integrity becoming a high priority for ensuring the safety and quality of drugs and devices, increasing demand for next-generation clinical trial supply & logistics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supply & Logistics for Pharmaceutical Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics for Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include Almac Group, AmerisourceBergen Corporation, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, ICON PLC, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Movianto, N-Side, Parexel International Corporation, PCI Pharma Services, Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics for Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • BA/BE Studies
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Sector
    • Clinical Trial Logistics and Distributions
    • Clinical Trial Manufacturing Services
    • Clinical Trial Supply Chain Management
  • Therapeutic Area
    • Blood Disorders
    • Digestive System Diseases
    • Infectious and Immune System Diseases
    • Neurological and Mental Disorders
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Clinical Trial Supply & Logistics for Pharmaceutical Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supply & Logistics for Pharmaceutical Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Trial Supply & Logistics for Pharmaceutical Market?
  4. What is the market share of the leading vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Trial Supply & Logistics for Pharmaceutical Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
5.1.1.2. Increased Focus on Drug Development
5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
5.1.2. Restraints
5.1.2.1. Increased Cost of Drug Development and Clinical Trials
5.1.3. Opportunities
5.1.3.1. Outsourcing of Clinical Trial Activity
5.1.3.2. Increased Focus on Generics and Biologics
5.1.3.3. Regulatory Approvals in Emerging Markets
5.1.4. Challenges
5.1.4.1. Logistics Challenges Across Nations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
6.1. Introduction
6.2. BA/BE Studies
6.3. Phase I
6.4. Phase II
6.5. Phase III
6.6. Phase IV
7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector
7.1. Introduction
7.2. Clinical Trial Logistics and Distributions
7.3. Clinical Trial Manufacturing Services
7.4. Clinical Trial Supply Chain Management
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Digestive System Diseases
8.4. Infectious and Immune System Diseases
8.5. Neurological and Mental Disorders
8.6. Oncology
9. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
12.3.2. Award, Recognition, & Expansion
12.3.2.1. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
12.3.2.2. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Almac Group
13.1.2. AmerisourceBergen Corporation
13.1.3. Bilcare Limited
13.1.4. Biocair International Limited
13.1.5. Catalent, Inc.
13.1.6. Clinigen Group PLC
13.1.7. DHL International GmbH by Deutsche Post AG
13.1.8. Eurofins Scientific SE
13.1.9. FedEx Corporation
13.1.10. ICON PLC
13.1.11. Infosys Limited
13.1.12. KLIFO A/S
13.1.13. Lonza Group
13.1.14. Marken
13.1.15. Movianto
13.1.16. N-Side
13.1.17. Parexel International Corporation
13.1.18. PCI Pharma Services
13.1.19. Seveillar Clinical Trial Supplies Pvt. Ltd.
13.1.20. SIRO Clinpharm Private Limited
13.1.21. Thermo Fisher Scientific, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2022 VS 2030
FIGURE 3. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET DYNAMICS
FIGURE 7. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2022 VS 2030 (%)
FIGURE 8. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2022 VS 2030 (%)
FIGURE 10. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
FIGURE 12. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • Almac Group
  • AmerisourceBergen Corporation
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • DHL International GmbH by Deutsche Post AG
  • Eurofins Scientific SE
  • FedEx Corporation
  • ICON PLC
  • Infosys Limited
  • KLIFO A/S
  • Lonza Group
  • Marken
  • Movianto
  • N-Side
  • Parexel International Corporation
  • PCI Pharma Services
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information